Floatz logo

Idursulfase

Mucopolysaccharidosis

Takedaprotein_peptidePhase 4 / ApprovedActive
BB
65/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
50/ 100
Competitive Position
95/ 100

Competitive context

5 Active assets in the Mucopolysaccharidosis cohort.

Asset / SponsorPhaseRating
.BETA.-GLUCURONIDASE (SYNTHETIC HUMAN), HOMOTETRAMER
Ultragenyx Pharmaceutical Inc
Phase 3BBB
Rituximab
Takeda
Phase 4BB
METHOTREXATE
Takeda
Phase 4BB
HUMAN IMMUNOGLOBULINS
Takeda
Phase 4B
Cyclophosphamide
Masonic Cancer Center, University of Minnesota
Phase 2B

View all 13 →

Same molecule, other indications

Idursulfase is also rated in:

mucopolysaccharidosis type 2Active
A
Indicative · Phase 4
86 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →